Poly Medicure Q2 Results: Europe Growth Surges 40%, FY27 Margin Guidance Raised | Business News
ET Now · 09 Nov 2026 · 10 min
Management interview of Poly Medicure Ltd (POLYMED), with 8 key numbers discussed.
- Himanshu Baid, MD, Poly Medicure
Poly Medicure reported strong momentum driven by European exports, where it added 15 new customers over the past six months and won long-term contracts. Based on sustained H1 margins exceeding 27%, the company raised its FY27 standalone EBITDA margin guidance to 26-27.5%, while maintaining consolidated guidance at 23-25%. Management noted that raw material prices remain elevated and shipping disruptions in the Middle East have tripled freight costs. Poly Medicure maintains a net cash position of Rs 460-470 cr.